April 25, 2013
IMBA researchers find potential therapeutic approach against kidney failure
Focal segmental glomerulosclerosis (FSGS) is a severe disease that results in complete kidney failure (end-stage renal disease). If untreated or if a patient does not respond to therapy, dialysis becomes essential 2-3 times per week. While several genetic mutations are described and drug abuse or hypertension can cause FSGS, for the majority of FSGS cases the underlying cause remains elusive.
March 10, 2013
Mutated gene causes nerve cell death
Researchers identify new mechanism in the onset of incurable nerve disease Stephen Hawking, a British astrophysicist, is likely to be the world's most famous person living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a progressive disease affecting motor neurons, nerve cells that control muscle function, and nearly always leads to death. Researchers at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) in Vienna have now identified a completely new mechanism in the onset of motor neuron diseases. Their findings could be the basis for future treatments for these presently incurable diseases.
December 10, 2012
“Network map” of pain genes identified
Genes involved in pain perception show remarkable similarities between flies and humans
July 24, 2012
How malnutrition leads to inflamed intestines
Researchers at the Institute of Molecular Biotechnology in Vienna, Austria, have uncovered how malnutrition, affecting millions of people, leads to diarrhoea, inflamed intestines and immune system disorders. This surprising result explains food effects that have been known for centuries and provides a molecular link between malnutrition and the bacteria which live in our intestines. The results will be published on 26 July 2012 in the journal Nature.
June 20, 2012
New play by Carl Djerassi at the Campus Vienna Biocenter
Vienna, 19 June 2012 Carl Djerassi, inventor of the pill and the author of numerous novels and plays, has chosen the Campus Vienna Biocenter (VBC) as the third performance venue for his new work 'Insufficiency' . The play will be presented by the VBC Amateur Dramatic Club; the actors are all scientists working on the campus. 'Insufficiency' joins Djerassi's other works in the genres he created: 'science-in-fiction' and 'science-in-theater', in which he brings scientific issues and everyday problems faced by researchers to the stage, making them accessible to non-scientists.